MORE►
verily
Dallas-based Verily Health Inc.'s newly granted patent describes a virtual-reality headset designed to automate the pupil-response exam an eye care professional typically performs by hand with a penlight, using an infrared eye-tracking subsystem and light-sealed compartments over each eye to measure how the pupils react to controlled light stimuli. According to the patent, the manual version of the test produces results that "vary by practitioner," and Verily's system is designed to improve the "sensitivity, consistency, and ease" of conducting it, as well as to flag asymmetric pupil sizes — anisocoria — alongside afferent pupil defects. Fig. 1 shows the system in use: a user wears the headset while a clinician runs the test from a tablet. [Composite image: Sources, U.S. Patent No. 12611100, Fig. 1; DI Studio]
Patented: Verily’s VR Headset Eye Tests and More North Texas Inventive Activity
by Dallas Innovates | Staff Report | May 20, 2026
Dallas-Fort Worth ranked No. 9 for patent activity out of 250 metros for the week of April 28 with a total of 127 patents granted.
by Sandra Engelland |
Mar 24, 2026
Verily graduated from Google X 10 years ago as one of Alphabet’s earliest “Other Bets," focusing on breakthrough science and health tech innovation. Its new round was led by Series X Capital, with participation from Alphabet, UCHealth, the University of Colorado Anschutz, and other investors.
MORE►
![At Google’s Midlothian data center on Nov. 14, Google executives joined Texas Governor Greg Abbott and other government leaders to announce the company’s $40 billion Texas investment. [Photo: Google]](https://s24806.pcdn.co/wp-content/uploads/2025/11/Platform-panel_47A1634_970_google-360x203.jpg)
by Quincy Preston |
Nov 16, 2025
Google CEO Sundar Pichai was in North Texas on Friday to announce the tech giant’s largest investment in a single state. The multiyear plan will add three Texas data center campuses, increase energy supply to the state’s grid, and train 1,700 electricians as the AI economy scales.
MORE►
by Lance Murray |
Oct 22, 2025
Unveiled at HLTH USA 2025, the Dallas-based precision health company’s Verily Me app blends clinical guidance and AI-driven tools to help people stay informed, connected, and proactive in managing their health.
MORE►
Who Made This Year’s AI 75 List? Meet the North Texans Leading the Pack in Artificial Intelligence
by Glenn Hunter | Apr 30, 2025
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
MORE►
by Nicole Ward, DRC Data Journalist |
Jul 25, 2024
Verily, Alphabet's health tech subsidiary, is shifting its headquarters to Dallas-Fort Worth's Cypress Waters development, positioning the Google sister company at the heart of a growing healthcare and tech ecosystem.
MORE►
by Glenn Hunter |
Apr 13, 2023
Digital maestro Stephen Gillett is driving the health-tech subsidiary of Alphabet Inc. to become more self-sufficient as it staffs up its new office at Cypress Waters.
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
Renderings from left: Frisco Station, Cypress Waters, CityLine
Evolutionary Vision: Leaders of Top North Texas Mixed-Use Developments Reveal What It Takes to Mark Success Across Decades
by Sandra Engelland | Feb 21, 2022
Robert Folzenlogen, Lucy Billingsley, and Michael Alost tell us what it takes to build a future-proof place for people and companies.
Their mixed-use developments—Frisco Station, Cypress Waters, and CityLIne—each started with a bold vision. A great location and North Texas' "transactional efficiency" didn't hurt.
Their mixed-use developments—Frisco Station, Cypress Waters, and CityLIne—each started with a bold vision. A great location and North Texas' "transactional efficiency" didn't hurt.
MORE►
by Dave Moore |
Dec 6, 2021
Mississauga, Ontario-based Evolve Biologics is a producer of plasma-derived therapeutics. The firm's CEO says the new, state-of-the-art, 200,000-SF Sachse facility "will be the foundation of our future growth and global strategy," with the capacity to process 1 million liters of plasma annually and a planned expansion to 2 million liters.
MORE►
by Alex Edwards |
Oct 14, 2021
It's the San Franciso company's first office in Texas. Verily expects to hire as many as 115 employees by the end of 2022.
MORE►
